Application of physiologically based pharmacokinetic models in chemical risk assessment

Journal of Toxicology

Volumn 2012, Issue , 2012, Pages

  Mumtaz, Moiz ^a   Fisher, Jeffrey ^b   Blount, Benjamin ^c   Ruiz, Patricia ^a  

^a AGENCY FOR TOXIC SUBSTANCES AND DISEASE REGISTRY   (United States)

^b NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^c NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,3',5' TRIIODOTHYRONINE; BENZENE; CARBON TETRACHLORIDE; CHLORPYRIFOS; DICHLOROMETHANE; PARATHION; TETRACHLOROETHYLENE; THYROTROPIN; THYROXINE; TRICHLOROETHYLENE; VINYL CHLORIDE;

BIOLOGICAL MONITORING; CHEMICAL STRESS; COMMUNITY; COMPUTER MODEL; DISEASE REGISTRY; DOSE RESPONSE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL STRESS; FUNDING; GOVERNMENT; HEALTH HAZARD; HUMAN; HYPOPHYSIS THYROID SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MEDICAL EDUCATION; MODEL; NONHUMAN; OCCUPATIONAL EXPOSURE; OUTCOME ASSESSMENT; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW; RISK ASSESSMENT; SCREENING; TARGET ORGAN; TRANSLATIONAL RESEARCH;

EID: 84859739254     PISSN: 16878191     EISSN: 16878205     Source Type: Journal    
DOI: 10.1155/2012/904603     Document Type: Review

References (82)

1. Tan Y.-M., Clewell H., Campbell J., Andersen M., Evaluating pharmacokinetic and pharmacodynamic interactions with computational models in supporting cumulative risk assessment International Journal of Environmental Research and Public Health 2011 8 5 1613 1630
2. Pang K. S., Durk M. R., Physiologically-based pharmacokinetic modeling for absorption, transport, metabolism and excretion Journal of Pharmacokinetics and Pharmacodynamics 2010 37 6 591 615
3. DeWoskin R. S., PBPK models in risk assessment-A focus on chloroprene Chemico-Biological Interactions 2007 166 13 352 359
4. Reddy M., Yang R. S. H., Clewell H. J., Andersen M. E., Physiologically Based Pharmacokinetic Modeling 2005 Hoboken, NJ, USA John Wiley Sons
5. Dixit R., Riviere J., Krishnan K., Andersen M. E., Toxicokinetics and physiologically based toxicokinetics in toxicology and risk assessment Journal of Toxicology and Environmental HealthPart B 2003 6 1 1 40 (Pubitemid 36020996)
6. DeWoskin R. S., Barone S., Clewell H. J., Setzer R. W., Improving the development and use of biologically based dose response models (BBDR) in risk assessment Human and Ecological Risk Assessment 2001 7 5 1091 1120
7. U.S. Environmental Protection Agency, Approaches for the Application of Physiologically Based Pharmacokinetic (PBPK) Models and Supporting Data in Risk Assessment, EPA/600/R-05/043F 2006 Washington, DC, USA U.S. Environmental Protection Agency
8. Clark L. H., Setzer R. W., Barton H. A., Framework for evaluation of physiologically-based pharmacokinetic models for use in safety or risk assessment Risk Analysis 2004 24 6 1697 1717 (Pubitemid 40076089)
9. Andersen M. E., Development of physiologically based pharmacokinetic and physiologically based pharmacodynamic models for applications in toxicology and risk assessment Toxicology Letters 1995 79 13 35 44
10. El-Masri H. A., Mumtaz M. M., Choudhary G., Cibulas W., De Rosa C. T., Applications of computational toxicology methods at the Agency for Toxic Substances and Disease Registry International Journal of Hygiene and Environmental Health 2002 205 1-2 63 69 (Pubitemid 34288650)
11. Mumtaz M. M., Knauf L. A., Reisman D. J., Peirano W. B., DeRosa C. T., Gombar V. K., Enslein K., Carter J. R., Blake B. W., Huque K. I., Ramanujam V. M. S., Assessment of effect levels of chemicals from quantitative structure- activity relationship (QSAR) models. I. Chronic lowest-observed-adverse- effect level (LOAEL) Toxicology Letters 1995 79 13 131 143
12. Ruiz P., Fowler B. A., Osterloh J. D., Fisher J., Mumtaz M., Physiologically based pharmacokinetic (PBPK) tool kit for environmental pollutantsmetals SAR and QSAR in Environmental Research 2010 21 7 603 618
13. Ruiz P., Mumtaz M., Osterloh J., Fisher J., Fowler B. A., Interpreting NHANES biomonitoring data, cadmium Toxicology Letters 2010 198 1 44 48
14. Ruiz P., Mumtaz M., Gombar V., Assessing the toxic effects of ethylene glycol ethers using Quantitative Structure Toxicity Relationship models Toxicology and Applied Pharmacology 2011 254 2 198 205
15. Demchuk E., Ruiz P., Wilson J. D., Scinicariello F., Pohl H. R., Fay M., Mumtaz M. M., Hansen H., De Rosa C. T., Computational toxicology methods in public health practice Toxicology Mechanisms and Methods 2008 18 2-3 119 135 (Pubitemid 351414965)
16. Clewell H. J., Gentry P. R., Gearhart J. M., Investigation of the potential impact of benchmark dose and pharmacokinetic modeling in noncancer risk assessment Journal of Toxicology and Environmental HealthPart A 1997 52 6 475 515
17. Agency for Toxic Substances and Disease Registry (ATSDR), Minimal risk levels for priority substances and guidance for derivation Federal Register 1996 61 125 33511 33520
18. Agency for Toxic Substances and Disease Registry (ATSDR), Toxicological Profile for Mercury Compounds, Update 1997 Atlanta, Ga, USA ATSDR
19. Agency for Toxic Substances and Disease Registry (ATSDR), Toxicological Profile for Mercury Compounds, Update 1995 Atlanta, Ga, USA ATSDR
20. Campbell J. L., Krishnan K., Clewell H. J., Andersen M.E., Mumtaz M., Kinetic interactions of chemical mixtures Principles and Practice of Mixtures Toxicology 2010 Weinheim, Germany Wiley
21. Kannan K., Sasso A., Georgopoulos P., Mumtaz M., Phramocokinetic mechanisms of interactions in chemical mixtures Principles and Practice of Mixtures Toxicology 2010 Weinheim, Germany Wiley
22. Mumtaz M. M., Durkin P. R., A weight-of-evidence approach for assessing interactions in chemical mixtures Toxicology and Industrial Health 1992 8 6 377 406 (Pubitemid 23128807)
23. Mumtaz M. M., De Rosa C. T., Groten J., Feron V. J., Hansen H., Durkin P. R., Estimation of toxicity of chemical mixtures through modeling of chemical interactions Environmental Health Perspectives 1998 106 6 1353 1360 (Pubitemid 29073878)
24. Agency for Toxic Substances and Disease Registry (ATSDR), Toxicological Profile of Chlorpyrifos 1997 Atlanta, GA, USA U.S. Department of Health and Human Services, Agency for Toxic Substances and Disease Registry
25. El-Masri H. A., Mumtaz M. M., Yushak M. L., Application of physiologically-based pharmacokinetic modeling to investigate the toxicological interaction between chlorpyrifos and parathion in the rat Environmental Toxicology and Pharmacology 2004 16 1-2 57 71 (Pubitemid 38314895)
26. Dennison J. E., Andersen M. E., Dobrev I. D., Mumtaz M. M., Yang R. S.H., PBPK modeling of complex hydrocarbon mixtures: gasoline Environmental Toxicology and Pharmacology 2004 16 1-2 107 119 (Pubitemid 38314898)
27. McLanahan E. D., Andersen M. E., Mumtaz M., Fisher J. W., BBPK model of the hypothalamic-pituitary-thyroid axis in the adult rat The Toxicologist 2007 96 1, article 394
28. Mclanahan E. D., Andersen M. E., Fisher J. W., A biologically based dose-response model for dietary iodide and the hypothalamic-pituitary-thyroid axis in the adult Rat: evaluation of iodide deficiency Toxicological Sciences 2008 102 2 241 253 (Pubitemid 351404896)
29. Dennison J. E., Bigelow P. L., Mumtaz M. M., Andersen M. E., Dobrev I. D., Yang R. S. H., Evaluation of potential toxicity from co-exposure to three CNS depressants (toluene, ethylbenzene, and xylene) under resting and working conditions using PBPK modeling Journal of Occupational and Environmental Hygiene 2005 2 3 127 135
30. Occupational Safety and Health Administration (OSHA), Air Contaminants. Code of Federal Regulations, Title 29, Part 1910.1000, 2004
31. Agency for Toxic Substances and Disease Registry (ATSDR), Toxicological Profile of Polychlorinated Biphenyls 2000 Atlanta, Ga, USA U.S. Department of Health and Human Services, Agency for Toxic Substances and Disease Registry
32. Lutz R. J., Dedrick R. L., Matthews H. B., A preliminary pharmacokinetic model for several chlorinated biphenyls in the rat Drug Metabolism and Disposition 1977 5 4 386 396 (Pubitemid 8327318)
33. Parham F. M., Kohn M. C., Matthews H. B., DeRosa C., Portier C. J., Using structural information to create physiologically based pharmacokinetic models for all polychlorinated biphenyls I. Tissue:Blood partition coefficients Toxicology and Applied Pharmacology 1997 144 2 340 347 (Pubitemid 27268356)
34. Parham F. M., Portier C. J., Using structural information to create physiologically based pharmacokinetic models for all polychlorinated biphenyls. II: rates of metabolism Toxicology and Applied Pharmacology 1998 151 1 110 116 (Pubitemid 28406657)
35. Edginton A. N., Joshi G., Have physiologically-based pharmacokinetic models delivered? Expert Opinion on Drug Metabolism and Toxicology 2011 7 8 929 934
36. Macey R. I., Oster G. F., Berkeley Madonna. Version 8.3.9 19962006 Berkeley Madonna
37. Mumtaz M. M., Ray M., Crowell S. R., Keys D., Fisher J., Ruiz P., Translational research to develop a human pbpk models tool kit-volatile organic compounds (VOCS) Journal of Toxicology and Environmental HealthPart A 2012 75 1 6 24
38. Yokley K., Tran H. T., Pekari K., Rappaport S., Riihimaki V., Rothman N., Waidyanatha S., Schlosser P. M., Physiologically-based pharmacokinetic modeling of benzene in humans: a Bayesian approach Risk Analysis 2006 26 4 925 943 (Pubitemid 44341856)
39. Thrall K. D., Vucelick M. E., Gies R. A., Zangar R. C., Weitz K. K., Poet T. S., Springer D. L., Grant D. M., Benson J. M., Comparative metabolism of carbon tetrachloride in rats, mice, and hamsters using gas uptake and PBPK modeling Journal of Toxicology and Environmental HealthPart A 2000 60 8 531 548
40. David R. M., Clewell H. J., Gentry P. R., Covington T. R., Morgott D. A., Marino D. J., Revised assessment of cancer risk to dichloromethane II. Application of probabilistic methods to cancer risk determinations Regulatory Toxicology and Pharmacology 2006 45 1 55 65
41. Covington T. R., Robinan Gentry P., Van Landingham C. B., Andersen M. E., Kester J. E., Clewell H. J., The use of Markov chain Monte Carlo uncertainty analysis to support a Public Health Goal for perchloroethylene Regulatory Toxicology and Pharmacology 2007 47 1 1 18 (Pubitemid 44765120)
42. Fisher J. W., Mahle D., Abbas R., A human physiologically based pharmacokinetic model for trichloroethylene and its metabolites, trichloroacetic acid and free trichloroethanol Toxicology and Applied Pharmacology 1998 152 2 339 359 (Pubitemid 28492276)
43. Clewell H. J., Gentry P. R., Gearhart J. M., Allen B. C., Andersen M. E., Comparison of cancer risk estimates for vinyl chloride using animal and human data with a PBPK model Science of the Total Environment 2001 274 13 37 66 (Pubitemid 32591381)
44. Clewell H. J., Gentry P. R., Covington T. R., Gearhart J. M., Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment Environmental Health Perspectives 2000 108 2 283 305 (Pubitemid 30420987)
45. Clewell H. J., Gentry P. R., Kester J. E., Andersen M. E., Evaluation of physiologically based pharmacokinetic models in risk assessment: an example with perchloroethylene Critical Reviews in Toxicology 2005 35 5 413 433 (Pubitemid 40962110)
46. Brown R. P., Delp M. D., Lindstedt S. L., Rhomberg L. R., Beliles R. P., Physiological parameter values for physiologically based pharmacokinetic models Toxicology and Industrial Health 1997 13 4 407 484 (Pubitemid 27314117)
47. Cowles A. L., Borgstedt H. H., Gillies A. J., Tissue weights and rates of blood flow in man for the prediction of anesthetic uptake and distribution Anesthesiology 1971 35 5 523 526
48. Corley R. A., Gordon S. M., Wallace L. A., Physiologically based pharmacokinetic modeling of the temperature- dependent dermal absorption of chloroform by humans following bath water exposures Toxicological Sciences 2000 53 1 13 23 (Pubitemid 30043598)
49. Agency for Toxic Substances and Disease Registry (ATSDR), Toxicological Profile for Perchloroethylene 1997 Atlanta, Ga, USA U.S. Department of Health and Human Services, Public Health Service
50. Agency for Toxic Substances and Disease Registry (ATSDR), Toxicological Profile for Trichloroethylene 1997 Atlanta, Ga, USA U.S. Department of Health and Human Services, Public Health Service
51. Agency for Toxic Substances and Disease Registry (ATSDR), Toxicological Profile for Dichloromethane 2000 Atlanta, Ga, USA U.S. Department of Health and Human Services, Public Health Service
52. Agency for Toxic Substances and Disease Registry (ATSDR), Toxicological Profile for Carbon Tetrachloride 2005 Atlanta, Ga, USA U.S. Department of Health and Human Services, Public Health Service
53. Agency for Toxic Substances and Disease Registry (ATSDR), Toxicological Profile for Vinyl Chloride 2006 Atlanta, Ga, USA U.S. Department of Health and Human Services, Public Health Service
54. Agency for Toxic Substances and Disease Registry (ATSDR), Toxicological Profile for Benzene 2007 Atlanta, Ga, USA U.S. Department of Health and Human Services, Public Health Service
55. Centers for Disease Control and Prevention (CDC), Fourth National Report on Human Exposure to Environmental Chemicals 2009 Atlanta, Ga, USA Division of Laboratory Sciences, National Center for Environmental Health
56. El-Masri H. A., Kenyon E. M., Development of a human physiologically based pharmacokinetic (PBPK) model for inorganic arsenic and its mono- and di-methylated metabolites Journal of Pharmacokinetics and Pharmacodynamics 2008 35 1 31 68 (Pubitemid 351420762)
57. Carrier G., Brunet R. C., Caza M., Bouchard M., A toxicokinetic model for predicting the tissue distribution and elimination of organic and inorganic mercury following exposure to methyl mercury in animals and humans. I. Development and validation of the model using experimental data in rats Toxicology and Applied Pharmacology 2001 171 1 38 49 (Pubitemid 32182293)
58. Carrier G., Bouchard M., Brunet R. C., Caza M., A toxicokinetic model for predicting the tissue distribution and elimination of organic and inorganic mercury following exposure to methyl mercury in animals and humans. II. Application and validation of the model in humans Toxicology and Applied Pharmacology 2001 171 1 50 60 (Pubitemid 32182294)
59. Choudhury H., Harvey T., Thayer W. C., Lockwood T. F., Stiteler W. M., Goodrum P. E., Hassett J. M., Diamond G. L., Urinary cadmium elimination as a biomarker of exposure for evaluating a cadmium dietary exposurebiokinetics model Journal of Toxicology and Environmental HealthPart A 2001 63 5 321 350 (Pubitemid 32643361)
60. Diamond G. L., Thayer W. C., Choudhury H., Pharmacokinetics/ pharmacodynamics (PK/PD) modeling of risks of kidney toxicity from exposure to cadmium: estimates of dietary risks in the U.S. population Journal of Toxicology and Environmental HealthPart A 2003 66 22 2141 2164 (Pubitemid 37421735)
61. Kjellstrm T., Nordberg G. F., A kinetic model of cadmium metabolism in the human being Environmental Research 1978 16 13 248 269 (Pubitemid 8369435)
62. Tan Y.-M., Liao K. H., Clewell H. J., Reverse dosimetry: interpreting trihalomethanes biomonitoring data using physiologically based pharmacokinetic modeling Journal of Exposure Science and Environmental Epidemiology 2007 17 7 591 603 (Pubitemid 350126884)
63. Hays S. M., Becker R. A., Leung H. W., Aylward L. L., Pyatt D. W., Biomonitoring equivalents: a screening approach for interpreting biomonitoring results from a public health risk perspective Regulatory Toxicology and Pharmacology 2007 47 1 96 109 (Pubitemid 44765127)
64. Tan Y. M., Liao K., Conolly R., Blount B., Mason A., Clewell H., Use of a physiologically based pharmacokinetic model to identify exposures consistent with human biomonitoring data for chloroform Journal of Toxicology and Environmental HealthPart A 2006 69 18 1727 1756 (Pubitemid 44174510)
65. Liao K. H., Tan Y. M., Clewell H. J., Development of a screening approach to interpret human biomonitoring data on volatile organic compounds: reverse dosimetry on biomonitoring data for trichloroethylene Risk Analysis 2007 27 5 1223 1236 (Pubitemid 350222035)
66. Clewell H. J., Tan Y. M., Campbell J. L., Andersen M. E., Quantitative interpretation of human biomonitoring data Toxicology and Applied Pharmacology 2008 231 1 122 133
67. Lyons M. A., Yang R. S. H., Mayeno A. N., Reisfeld B., Computational toxicology of chloroform: reverse dosimetry using Bayesian inference, Markov chain Monte Carlo simulation, and human biomonitoring data Environmental Health Perspectives 2008 116 8 1040 1046
68. Georgopoulos P. G., Roy A., Gallo M. A., Reconstruction of short-term multi-route exposure to volatile organic compounds using physiologically based pharmacokinetic models Journal of Exposure Analysis and Environmental Epidemiology 1994 4 3 309 328 (Pubitemid 24335163)
69. Weisel C. P., Kim H., Haltmeier P., Klotz J. B., Exposure estimates to disinfection by-products of chlorinated drinking water Environmental Health Perspectives 1999 107 2 103 110 (Pubitemid 29137720)
70. Kirman C. R., Aylward L. L., Blount B. C., Pyatt D. W., Hays S. M., Evaluation of NHANES biomonitoring data for volatile organic chemicals in blood: application of chemical-specific screening criteria Journal of Exposure Science and Environmental Epidemiology 2012 22 1 24 34
71. Aylward L. L., Kirman C. R., Blount B. C., Hays S. M., Chemical-specific screening criteria for interpretation of biomonitoring data for volatile organic compounds (VOCs)application of steady-state PBPK model solutions Regulatory Toxicology and Pharmacology 2010 58 1 33 44
72. Hays S. M., Aylward L. L., LaKind J. S., Bartels M. J., Barton H. A., Boogaard P. J., Brunk C., DiZio S., Dourson M., Goldstein D. A., Lipscomb J., Kilpatrick M. E., Krewski D., Krishnan K., Nordberg M., Okino M., Tan Y.-M., Viau C., Yager J. W., Guidelines for the derivation of biomonitoring equivalents: report from the biomonitoring equivalents expert workshop Regulatory Toxicology and Pharmacology 2008 51 3, supplement S4 S15
73. Forsby A., Blaauboer B., Integration of in vitro neurotoxicity data with biokinetic modelling for the estimation of in vivo neurotoxicity Human and Experimental Toxicology 2007 26 4 333 338 (Pubitemid 46733356)
74. Blaauboer B. J., The integration of data on physico-chemical properties, in vitro -derived toxicity data and physiologically based kinetic and dynamic as modelling a tool in hazard and risk assessment. A commentary Toxicology Letters 2003 138 1-2 161 171 (Pubitemid 36139973)
75. De Buck S. S., Mackie C. E., Physiologically based approaches towards the prediction of pharmacokinetics: in vitro-in vivo extrapolation Expert Opinion on Drug Metabolism and Toxicology 2007 3 6 865 878 (Pubitemid 350285340)
76. Blaauboer B. J., Biokinetic modeling and in vitro-in vivo extrapolations Journal of Toxicology and Environmental HealthPart B 2010 13 24 242 252
77. Louisse J., de Jong E., van de Sandt J. J. M., Blaauboer B. J., Woutersen R. A., Piersma A. H., Rietjens I. M. C. M., Verwei M., The use of in vitro toxicity data and physiologically based kinetic modeling to predict dose-response curves for in vivo developmental toxicity of glycol ethers in rat and man Toxicological Sciences 2010 118 2 470 484
78. Sohn M. D., McKone T. E., Blancato J. N., Reconstructing population exposures from dose biomarkers: inhalation of trichloroethylene (TCE) as a case study Journal of Exposure Analysis and Environmental Epidemiology 2004 14 3 204 213 (Pubitemid 38765943)
79. McKone T. E., Linking a PBPK model for chloroform with measured breath concentrations in showers: implications for dermal exposure models Journal of Exposure Analysis and Environmental Epidemiology 1993 3 3 339 365
80. Bogen K. T., McKone T. E., Linking indoor air and pharmacokinetic models to assess tetrachloroethylene risk Risk Analysis 1988 8 4 509 520 (Pubitemid 19037084)
81. Rotroff D. M., Wetmore B. A., Dix D. J., Ferguson S. S., Clewell H. J., Houck K. A., LeCluyse E. L., Andersen M. E., Judson R. S., Smith C. M., Sochaski M. A., Kavlock R. J., Boellmann F., Martin M. T., Reif D. M., Wambaugh J. F., Thomas R. S., Incorporating human dosimetry and exposure into high-throughput in vitro toxicity screening Toxicological Sciences 2010 117 2 348 358
82. Wetmore B. A., Wambaugh J. F., Ferguson S. S., Sochaski M. A., Rotroff D. M., Freeman K., Clewell H. J., Dix D. J., Andersen M. E., Houck K. A., Allen B., Judson R. S., Singh R., Kavlock R. J., Richard A. M., Thomas R. S., Integration of dosimetry, exposure, and high-throughput screening data in chemical toxicity assessment Toxicological Sciences 2012 125 1 157 174